Reply to The Letter to the Editors (ACR-19-1134) Opioid Use in Patients with Acute Gout.

Clicks: 361
ID: 95641
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #7 of 23 articles by views in arthritis care & research

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
We would like to thank the editors for providing us an opportunity to further the discussion regarding opioid use for management of acute gout and Dr. Schlesinger and colleagues for highlighting yet another study describing the burden of opioid prescription for gout management. As appropriately pointed out, opioids do not reduce the inflammation of an acute gout attack and conventional anti-inflammatories like colchicine, non-steroidal anti-inflammatory drugs (NSAIDs), and steroids can substantially reduce pain within the first 24 hours of administration.
Reference Key
dalal2020replyarthritis Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Dalal, Deepan S;Mbuyi, Nadine;Reginato, Anthony;
Journal arthritis care & research
Year 2020
DOI
10.1002/acr.24165
URL
Keywords
adalimumab hidradenitis suppurativa kyrle disease tumor necrosis factor inhibition

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.